Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Iannone

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volumeAndrea G Rockall, Norbert Avril, Raymond Lam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
Blood|September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 StudyStella M Davies, Robert Iannone, Todd A Alonzo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 27, 2012
Repeatability of edited lactate and other metabolites in astrocytoma at 3TMary A McLean, Amy Sun, Thomas E Bradstreet, et al.
Plos One|June 25, 2015
Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive AspergillosisDionysios Neofytos, Radha Railkar, Kathleen M Mullane, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Cancer|July 19, 2011
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology GroupTodd M Cooper, Janet Franklin, Robert B Gerbing, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2014
Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recurrent ovarian carcinoma: test-retest measurements for tumor FDG uptake, diameter, and volumeAndrea G Rockall, Norbert Avril, Raymond Lam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
Blood|September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2019
A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 StudyStella M Davies, Robert Iannone, Todd A Alonzo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 27, 2012
Repeatability of edited lactate and other metabolites in astrocytoma at 3TMary A McLean, Amy Sun, Thomas E Bradstreet, et al.
Plos One|June 25, 2015
Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive AspergillosisDionysios Neofytos, Radha Railkar, Kathleen M Mullane, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Cancer|July 19, 2011
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology GroupTodd M Cooper, Janet Franklin, Robert B Gerbing, et al.
Pageof 3